BAX
vs
S&P 500
Over the past 12 months, BAX has underperformed S&P 500, delivering a return of -24% compared to the S&P 500's 24% growth.
Stocks Performance
BAX vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
Abbott Laboratories
NYSE:ABT
|
||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
||
US |
Boston Scientific Corp
NYSE:BSX
|
||
US |
Stryker Corp
NYSE:SYK
|
||
IE |
Medtronic PLC
NYSE:MDT
|
||
US |
Becton Dickinson and Co
NYSE:BDX
|
||
DE |
Siemens Healthineers AG
XETRA:SHL
|
||
US |
Edwards Lifesciences Corp
NYSE:EW
|
||
US |
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Performance Gap
BAX vs S&P 500
US |
Abbott Laboratories
NYSE:ABT
|
||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
||
US |
Boston Scientific Corp
NYSE:BSX
|
||
US |
Stryker Corp
NYSE:SYK
|
||
IE |
Medtronic PLC
NYSE:MDT
|
||
US |
Becton Dickinson and Co
NYSE:BDX
|
||
DE |
Siemens Healthineers AG
XETRA:SHL
|
||
US |
Edwards Lifesciences Corp
NYSE:EW
|
||
US |
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Performance By Year
BAX vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
Abbott Laboratories
NYSE:ABT
|
||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
||
US |
Boston Scientific Corp
NYSE:BSX
|
||
US |
Stryker Corp
NYSE:SYK
|
||
IE |
Medtronic PLC
NYSE:MDT
|
||
US |
Becton Dickinson and Co
NYSE:BDX
|
||
DE |
Siemens Healthineers AG
XETRA:SHL
|
||
US |
Edwards Lifesciences Corp
NYSE:EW
|
||
US |
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Competitors Performance
Baxter International Inc vs Peers
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
G
|
GE Vernova LLC
NYSE:GEV
|
|
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
|
US |
Schlumberger NV
NYSE:SLB
|
||
US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
|
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
||
US |
R
|
Reddit Inc
NYSE:RDDT
|
|
CH |
G
|
Galderma Group AG
SIX:GALD
|
|
US |
Halliburton Co
NYSE:HAL
|
||
LU |
Tenaris SA
MIL:TEN
|
||
IN |
Jio Financial Services Ltd
NSE:JIOFIN
|
Baxter International Inc
Glance View
Baxter International Inc. finds its roots in the early 1930s, a time when the healthcare landscape was vastly different. Founded by Donald Baxter, a medical doctor seeking to improve the quality and safety of intravenous therapy, the company initially focused on researching and developing safe ways to provide patients with sterile intravenous solutions. As the years unfolded, Baxter transformed itself from a small operation into a globally recognized healthcare giant. Today, it operates in the realm of lifesaving medical products and services, specializing in the development of essential pharmaceuticals, clinical nutrition for hospitals, advanced kidney care solutions, and critical care technology that healthcare providers depend on daily. Central to Baxter's business model is its commitment to innovation and improving patient outcomes, which drives its success and profitability. By leveraging its expertise in areas like renal and hospital products, Baxter is able to cultivate a diversified portfolio. This diversification not only helps the company mitigate risks but also strengthens its market position. Revenue streams are generated through the manufacture and sale of medical devices and pharmaceuticals, catering mostly to hospitals, clinics, and renal care centers worldwide. Baxter consistently reinvests in its research and development, aiming to pioneer novel therapies and products that address the evolving needs of the healthcare sector, ensuring that it remains a key player in the ongoing story of medical progress.